首页> 外文期刊>Nature >Nonsense mutation in the LGR4 gene is associated with several human diseases and other traits
【24h】

Nonsense mutation in the LGR4 gene is associated with several human diseases and other traits

机译:LGR4基因的无意义突变与几种人类疾病和其他特征有关

获取原文
获取原文并翻译 | 示例
       

摘要

Low bone mineral density (BMD) is used as a parameter of osteoporosis. Genome-wide association studies of BMD have hitherto focused on BMD as a quantitative trait, yielding common variants of small effects that contribute to the population diversity in BMD1"7. Here we use BMD as a dichotomous trait, searching for variants that may have a direct effect on the risk of pathologically low BMD rather than on the regulation of BMD in the healthy population. Through whole-genome sequencing of Icelandic individuals, we found a rare nonsense mutation within the leucine-rich-repeat-containing G-protein-coupled receptor 4 (LGR4) gene (c.376C>T) that is strongly associated with low BMD, and with osteoporotic fractures. This mutation leads to termination of LGR4 at position 126 and fully disrupts its function. The C.376OT mutation is also associated with electrolyte imbalance, late onset of men-arche and reduced testosterone levels, as well as an increased risk of squamous cell carcinoma of the skin and biliary tract cancer. Interestingly, the phenotype of carriers of the c.376C>T mutation overlaps that of Lgr4 mutant mice.%一项在来自数干名冰岛人的全基因组序列数据rn中搜寻变异体的工作(这些变异体对出现从病rn理上来说较低的骨矿物密度的风险可能会有直rn接影响),识别出了一个罕见的无意义突变,rn除了那些与骨生理相关的表现型外,它还与一rn系列其他表现型相关。
机译:低骨矿物质密度(BMD)用作骨质疏松症的参数。迄今为止,BMD的全基因组关联研究一直将BMD作为一种定量性状,产生了一些小效应的常见变异,这些变异有助于BMD1“ 7的种群多样性。在这里,我们使用BMD作为二分性状,寻找可能具有遗传多样性的变异。直接影响健康人群中病理性BMD的风险而不是BMD的调节通过冰岛个体的全基因组测序,我们发现在富含亮氨酸重复序列的G蛋白偶联物中存在罕见的无意义突变受体4(LGR4)基因(c.376C> T)与低BMD和骨质疏松性骨折密切相关,这种突变导致LGR4在126位终止,并完全破坏其功能。电解质紊乱,男性足弓起病较晚,睾丸激素水平降低,以及皮肤鳞状细胞癌和胆道癌的风险增加。 c.376C> T突变的携带者与Lgr4突变小鼠的携带者重叠。%根据在来自数干名冰岛人的全基因组序列数据rn中搜寻变异体的工作(这些变异体对出现从病rn理上来说根本的骨矿物密度的风险可能会有直rn接影响),识别出了一个罕见的无意义突变,rn除了那些与骨生理相关的表现型外,它还与一rn系列其他表现型相关。

著录项

  • 来源
    《Nature》 |2013年第7450期|517-520|共4页
  • 作者单位

    DeCODE Genetics/Amgen, 101 Reykjavik, Iceland;

    DeCODE Genetics/Amgen, 101 Reykjavik, Iceland;

    DeCODE Genetics/Amgen, 101 Reykjavik, Iceland;

    DeCODE Genetics/Amgen, 101 Reykjavik, Iceland;

    DeCODE Genetics/Amgen, 101 Reykjavik, Iceland;

    DeCODE Genetics/Amgen, 101 Reykjavik, Iceland;

    DeCODE Genetics/Amgen, 101 Reykjavik, Iceland;

    DeCODE Genetics/Amgen, 101 Reykjavik, Iceland,Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden;

    DeCODE Genetics/Amgen, 101 Reykjavik, Iceland;

    DeCODE Genetics/Amgen, 101 Reykjavik, Iceland;

    DeCODE Genetics/Amgen, 101 Reykjavik, Iceland;

    DeCODE Genetics/Amgen, 101 Reykjavik, Iceland;

    DeCODE Genetics/Amgen, 101 Reykjavik, Iceland;

    Department of Biochemistry and Molecular Biology, University of Iceland, Biomedical Center, Faculty of Medicine, 101 Reykjavik, Iceland;

    Department of Biochemistry and Molecular Biology, University of Iceland, Biomedical Center, Faculty of Medicine, 101 Reykjavik, Iceland;

    Garvan Institute of Medical Research, 2010 Sydney, Australia,St Vincent's Hospital, 2010 Sydney, Australia. ,University of New South Wales (UNSW), 2010 Sydney, Australia;

    Garvan Institute of Medical Research, 2010 Sydney, Australia,University of New South Wales (UNSW), 2010 Sydney, Australia;

    Garvan Institute of Medical Research, 2010 Sydney, Australia,St Vincent's Hospital, 2010 Sydney, Australia. ,University of New South Wales (UNSW), 2010 Sydney, Australia,University of Notre Dame Australia (UNDA), 2010 Sydney, Australia;

    Center for Clinical and Basic Research (CCBR), 2750 Ballerup,Denmark;

    Department of Biochemistry and Molecular Biology, University of Iceland, Biomedical Center, Faculty of Medicine, 101 Reykjavik, Iceland;

    Department of Pathology, Landspitali, The National University Hospital of Iceland, 101 Reykjavik, Iceland,Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland,Icelandic Cancer Registry, 105 Reykjavik, Iceland;

    Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland,Icelandic Cancer Registry, 105 Reykjavik, Iceland;

    Laboratory in Mjodd (RAM), Icelandic Medical Center (Laeknasetrid), 109 Reykjavik, Iceland;

    Department of Gastroenterology, Landspitali, The National University Hospital of Iceland, 101 Reykjavik, Iceland;

    Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland,Department of Surgery, Landspitali, The National University Hospital of Iceland, 101 Reykjavik, Iceland;

    Department of Orthopedic Surgery, Akureyri Hospital,600 Akureyri, Iceland,lnstitution of Health Science, University of Akureyri, 600 Akureyri, Iceland;

    Department of Clinical Biochemistry, Landspitali, The National University Hospital of Iceland, 101 Reykjavik, Iceland;

    DeCODE Genetics/Amgen, 101 Reykjavik, Iceland;

    DeCODE Genetics/Amgen, 101 Reykjavik, Iceland;

    Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland,Department of Endocrinology and Metabolism, Landspitali,The National University Hospital of Iceland,101 Reykjavik, Iceland.517-520;

    DeCODE Genetics/Amgen, 101 Reykjavik, Iceland;

    DeCODE Genetics/Amgen, 101 Reykjavik, Iceland,Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland;

    DeCODE Genetics/Amgen, 101 Reykjavik, Iceland,Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:53:34

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号